Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, Connecticut
Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, Connecticut.
J Nucl Med. 2019 Aug;60(8):1140-1146. doi: 10.2967/jnumed.118.219766. Epub 2019 Mar 15.
The 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) enzyme converts cortisone to cortisol and participates in the regulation of glucocorticoid levels in tissues. 11β-HSD1 is expressed in the liver, kidney, adipose tissue, placenta, and brain. 11β-HSD1 is a target for treatment of depression, anxiety, posttraumatic stress disorder, and also against age-related cognitive function and memory loss. In this study, we evaluated the radiotracer C-AS2471907 (3-(2-chlorophenyl)-4-(methyl-)-5-[2-[2,4,6-trifluorophenoxy]propan-2-yl]-4-1,2,4-triazole) to image 11β-HSD1 availability in the human brain with PET. Fifteen subjects were included in the study. All subjects underwent one 2-h scan after a bolus administration of C-AS2471907. Two subjects underwent an additional scan after blockade with the selective and high-affinity 11β-HSD1 inhibitor ASP3662 to evaluate C-AS2471907 nondisplaceable distribution volume. Five subjects also underwent an additional scan to evaluate the within-day test-retest variability of C-AS2471907 volumes of distribution (). C-AS2471907 time-activity curves were best fitted by the 2-tissue-compartment (2TC) model. C-AS2471907 exhibited a regionally varying pattern of uptake throughout the brain. The of C-AS2471907 ranged from 3.7 ± 1.5 mL/cm in the caudate nucleus to 14.5 ± 5.3 mL/cm in the occipital cortex, with intermediate values in the amygdala, white matter, cingulum, insula, frontal cortex, putamen, temporal and parietal cortices, cerebellum, and thalamus (from lowest to highest ). From the blocking scans, nondisplaceable distribution volume was determined to be 0.16 ± 0.04 mL/cm for C-AS2471907. Thus, nearly all uptake was specific and the binding potential ranged from 22 in the caudate to 90 in the occipital cortex. Test-retest variability of 2TC values was less than 10% in most large cortical regions (14% in parietal cortex) and ranged from 14% (cerebellum) to 51% (amygdala) in other regions. The intraclass correlation coefficient of 2TC values ranged from 0.55 in the white matter to 0.98 in the cerebellum. C-AS2471907 has a high fraction of specific binding in vivo in humans and reasonable within-day reproducibility of binding parameters.
11β-羟甾类脱氢酶 1 型(11β-HSD1)将皮质酮转化为皮质醇,并参与组织中糖皮质激素水平的调节。11β-HSD1 在肝脏、肾脏、脂肪组织、胎盘和大脑中表达。11β-HSD1 是治疗抑郁症、焦虑症、创伤后应激障碍以及对抗与年龄相关的认知功能和记忆丧失的靶点。在这项研究中,我们评估了放射性示踪剂 C-AS2471907(3-(2-氯苯基)-4-(甲基)-5-[2-[2,4,6-三氟苯氧基]丙-2-基]-4-1,2,4-三唑)用于 PET 成像人类大脑中 11β-HSD1 的可用性。15 名受试者参与了这项研究。所有受试者在静脉注射 C-AS2471907 后进行了一次 2 小时的扫描。两名受试者在使用选择性和高亲和力 11β-HSD1 抑制剂 ASP3662 阻断后进行了额外的扫描,以评估 C-AS2471907 不可置换分布容积。五名受试者还进行了额外的扫描,以评估 C-AS2471907 分布容积的日内测试-重测变异性()。C-AS2471907 的时间-活性曲线通过 2 组织室(2TC)模型拟合得最好。C-AS2471907 在整个大脑中表现出区域变化的摄取模式。C-AS2471907 的范围从尾状核的 3.7±1.5 mL/cm 到枕叶的 14.5±5.3 mL/cm,杏仁核、白质、扣带回、脑岛、额叶、壳核、颞叶和顶叶皮质、小脑和丘脑的中间值(从最低到最高)。从阻断扫描中,确定 C-AS2471907 的不可置换分布容积为 0.16±0.04 mL/cm。因此,几乎所有的摄取都是特异性的,结合潜力范围从尾状核的 22 到枕叶的 90。2TC 值的测试-重测变异性在大多数大皮质区域(顶叶为 14%)小于 10%,在其他区域(杏仁核为 14%,小脑为 51%)。2TC 值的组内相关系数范围从白质的 0.55 到小脑的 0.98。C-AS2471907 在人体内具有高比例的特异性结合,并且结合参数具有合理的日内可重复性。